River Biomedics

Developer of stem-cell-derived organoid models for cardiac drug discovery

placeEnschede, Overijssel, Netherlands calendar_todayFounded 2018 groups11 employees language riverbiomedics.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 24 times.

YearFilings
20211
20231
20261

Social engagement

Social engagement: 2.2K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include KIKK Capital, Oost NL, BioGeneration Ventures.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%

Recent activity

26 Jan 2026
Partnership
Metatissue
14 Nov 2025
Event
TechMed Event
1 Sep 2025
Partnership
Harborn
Coming soon